Scientific Advisory Board

The Science Advisory Board for the Pitt Hopkins Research Foundation is comprised of top Scientists around the country who are able to offer their expertise in advising the PHRF Board of Directors. Duties include reviewing grant proposals and budgets and offering expert opinions about the direction of the Foundation in research into Pitt Hopkins syndrome.

•  CHIEF SCIENCE OFFICER – Sarah Harris, PhD., Drug Development and Translational Medicine Consultant

  • Dr. Marcelo Wood, Ph.D., University of California, Irvine, Associate Professor; Director, Interdepartmental Neuroscience Program; Department of Neurobiology and Behavior; Center for the Neurobiology of Learning and Memory
  • Dr. Craig M. Powell, M.D., Ph.D., Associate Professor; Ed and Sue Rose Distinguished Professorship in Neurology; Departments of Neurology & Neurotherapeutics, Psychiatry; University of Texas Southwestern Medical Center
  • Dr. Stanley Nelson, M.D., Professor in Residence, Human Genetics; Director, DNA Microarray Technology; Co-Director, Center for Duchenne Muscular Dystrophy; University of California Los Angeles
  • Dr. Joel Gottesfeld, Ph.D., Professor of Molecular Biology, Scripps Research Institute, Associate Editor, Journal of Biological Chemistry
  • Dr. Mary Jacena Leigh, M.D., Developmental Behavioral Pediatrics, University of California Davis, MIND Institute
  • Dr. Joachim Herz, M.D., Professor, Thomas O. and Cinda Hicks Family Distinguished Chair in Alzheimer’s Disease Research; Departments of Molecular Genetics, Neurology & Neurotherapeutics, Neuroscience; Graduate Program in Integrative Biology, University of Texas Southwestern Medical Center
  • Dr. Michael Tranfaglia, M.D., Medical Director, Chief Scientific Officer, FRAXA Research Foundation
  • Dr. Shafali Jeste, M.D., Principal Investigator/Assistant Professor in Psychiatry and Neurology, UCLA Center for Autism Research and Treatment (CART)
  • Dr. Sean Ekins, Ph.D, DSc, CSO, Hereditary Neuropathy Foundation, Adjunct Professor, Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill; Adjunct Professor, Robert Wood Johnson Medical School, University of Medicine and Dentistry, New Jersey (Now Rutgers University); Adjunct Associate Professor, School of Pharmacy Department of Pharmaceutical Sciences, University of Maryland
  • Dr. Robert H. Ring, Ph.D, Chief Executive Officer, Kaerus Bioscience Ltd
  • Dr. Aaron C. Gerlach, Ph.D, Director, Icagen, Inc.
  • Peter Lloyd-Thomas, M.Eng, MBA, Management Consultant, Independent Researcher in the Translation of Autism Science into Therapy
  • Dr. Andrew J Kennedy, Ph.D., Former Associate Professor of Neuroscience and Biochemistry at Bates College

OVER 94% OF ALL FUNDS DONATED GO TO RESEARCH

Our board and officers are parents and professionals who work diligently to ensure over 94% of all funds donated go toward research and our mission of finding a cure.

X